BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 34773595)

  • 21. Surgery with Radical Intent: Is There an Indication for G3 Neuroendocrine Neoplasms?
    Merola E; Rinke A; Partelli S; Gress TM; Andreasi V; Kollár A; Perren A; Christ E; Panzuto F; Pascher A; Jann H; Arsenic R; Cremer B; Kaemmerer D; Kump P; Lipp RW; Agaimy A; Wiedenmann B; Falconi M; Pavel ME
    Ann Surg Oncol; 2020 May; 27(5):1348-1355. PubMed ID: 31720931
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intratumoral Fibrosis and Tumor Growth Pattern as Prognostic Factors in Optimally Resected Pancreatic Neuroendocrine Neoplasms: An Analysis of 168 Cases.
    Chatterjee D; Trikalinos NA; Williams GA; Liu J; Hawkins WG; Hammill C
    Pancreas; 2020 Feb; 49(2):255-260. PubMed ID: 32011527
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The clinicopathologic and operative characteristics of patients with small nonfunctioning pancreatic neuroendocrine tumors.
    Ha S; Song KB; Hong S; Shin D; Park Y; Kwon J; Lee W; Jun E; Lee JH; Hwang DW; Kim SC
    ANZ J Surg; 2021 Jul; 91(7-8):E484-E492. PubMed ID: 34291544
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Meta-Analysis of Prognostic Factors for Recurrence of Resected Well-Differentiated Pancreatic Neuroendocrine Tumors.
    Li Y; Fan G; Yu F; Tian C; Tan H
    Neuroendocrinology; 2021; 111(12):1231-1237. PubMed ID: 33370727
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression Patterns and Prognostic Value of DNA Damage Repair Proteins in Resected Pancreatic Neuroendocrine Neoplasms.
    Hua J; Shi S; Xu J; Wei M; Zhang Y; Liu J; Zhang B; Yu X
    Ann Surg; 2022 Feb; 275(2):e443-e452. PubMed ID: 32209898
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic factors for relapse in resected gastroenteropancreatic neuroendocrine neoplasms: A systematic review and meta-analysis.
    Broadbent R; Wheatley R; Stajer S; Jacobs T; Lamarca A; Hubner RA; Valle JW; Amir E; McNamara MG
    Cancer Treat Rev; 2021 Dec; 101():102299. PubMed ID: 34662810
    [TBL] [Abstract][Full Text] [Related]  

  • 27. EUS-guided radiofrequency ablation as an alternative to surgery for pancreatic neuroendocrine neoplasms: Who should we treat?
    Larghi A; Rizzatti G; Rimbaş M; Crino SF; Gasbarrini A; Costamagna G
    Endosc Ultrasound; 2019; 8(4):220-226. PubMed ID: 31249164
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Indications for resection and perioperative outcomes of surgery for pancreatic neuroendocrine neoplasms in Germany: an analysis of the prospective DGAV StuDoQ|Pancreas registry.
    Mintziras I; Keck T; Werner J; Fichtner-Feigl S; Wittel U; Senninger N; Vowinkel T; Köninger J; Anthuber M; Geißler B; Bartsch DK;
    Surg Today; 2019 Dec; 49(12):1013-1021. PubMed ID: 31240463
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Surgical Principles in the Management of Pancreatic Neuroendocrine Neoplasms.
    Andreasi V; Muffatti F; Guarneri G; Falconi M; Partelli S
    Curr Treat Options Oncol; 2020 Apr; 21(6):48. PubMed ID: 32350693
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patterns of Recurrence after Resection for Pancreatic Neuroendocrine Tumors: Who, When, and Where?
    Marchegiani G; Landoni L; Andrianello S; Masini G; Cingarlini S; D'Onofrio M; De Robertis R; Davì M; Capelli P; Manfrin E; Amodio A; Paiella S; Malleo G; Damoli I; Miotto M; Bianchi B; Nessi C; Vivani E; Scarpa A; Salvia R; Bassi C
    Neuroendocrinology; 2019; 108(3):161-171. PubMed ID: 30481765
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Poorly differentiated resectable pancreatic cancer: is upfront resection worthwhile?
    Crippa S; Partelli S; Zamboni G; Barugola G; Capelli P; Inama M; Bassi C; Pederzoli P; Falconi M
    Surgery; 2012 Sep; 152(3 Suppl 1):S112-9. PubMed ID: 22766365
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pancreatic neuroendocrine neoplasms at magnetic resonance imaging: comparison between grade 3 and grade 1/2 tumors.
    Guo C; Chen X; Xiao W; Wang Q; Sun K; Wang Z
    Onco Targets Ther; 2017; 10():1465-1474. PubMed ID: 28331340
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The size of well differentiated pancreatic neuroendocrine tumors correlates with Ki67 proliferative index and is not associated with age.
    Partelli S; Muffatti F; Rancoita PMV; Andreasi V; Balzano G; Crippa S; Doglioni C; Rubini C; Zamboni G; Falconi M
    Dig Liver Dis; 2019 May; 51(5):735-740. PubMed ID: 30723019
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Medical Treatment of Advanced Pancreatic Neuroendocrine Neoplasms.
    Palmieri LJ; Dermine S; Barré A; Dhooge M; Brezault C; Cottereau AS; Coriat R
    J Clin Med; 2020 Jun; 9(6):. PubMed ID: 32549203
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk Factors for Recurrence in Pancreatic Neuroendocrine Tumor and Size as a Surrogate in Determining the Treatment Strategy: A Korean Nationwide Study.
    Kwon W; Jang JY; Song KB; Hwang DW; Kim SC; Heo JS; Choi DW; Hwang HK; Kang CM; Yoon YS; Han HS; Park JS; Hong TH; Cho CK; Ahn KS; Lee H; Lee SE; Jeong CY; Roh YH; Kim HJ;
    Neuroendocrinology; 2021; 111(8):794-804. PubMed ID: 33002889
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment of the Role of Leptin and Adiponectinas Biomarkers in Pancreatic Neuroendocrine Neoplasms.
    Bocian-Jastrzębska A; Malczewska-Herman A; Rosiek V; Kos-Kudła B
    Cancers (Basel); 2023 Jul; 15(13):. PubMed ID: 37444627
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of Resection Margin Distance on Survival of Pancreatic Cancer: A Systematic Review and Meta-Analysis.
    Kim KS; Kwon J; Kim K; Chie EK
    Cancer Res Treat; 2017 Jul; 49(3):824-833. PubMed ID: 27561314
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical Characteristics and Management of Functional Pancreatic Neuroendocrine Neoplasms: A Single Institution 20-Year Experience with 286 Patients.
    Qu Y; Li H; Wang X; Chen Y; Guo Q; Pei Y; Du J; Dou J; Ba J; Lv Z; Mu Y
    Int J Endocrinol; 2020; 2020():1030518. PubMed ID: 33204258
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An Insight on Functioning Pancreatic Neuroendocrine Neoplasms.
    Bevere M; Gkountakos A; Martelli FM; Scarpa A; Luchini C; Simbolo M
    Biomedicines; 2023 Jan; 11(2):. PubMed ID: 36830839
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serotonin immunoreactive pancreatic neuroendocrine neoplasm associated with main pancreatic duct dilation: a recognizable entity with excellent long-term outcome.
    Dioguardi Burgio M; Cros J; Panvini N; Depoilly T; Couvelard A; Ruszniewski P; de Mestier L; Hentic O; Sauvanet A; Dokmak S; Faccinetto A; Ronot M; Vilgrain V
    Eur Radiol; 2021 Nov; 31(11):8671-8681. PubMed ID: 33977308
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.